Literature DB >> 11979019

Maturity-onset diabetes of the young (MODY): genetic and clinical characteristics.

Gilberto Velho1, Jean-Jacques Robert.   

Abstract

Maturity-onset diabetes of the young (MODY) is a genetically and clinically heterogeneous subtype of familial diabetes mellitus characterized by early onset, autosomal dominant inheritance and primary defects of insulin secretion. Mutations in six genes cause most of the MODY cases. These genes encode the enzyme glucokinase and the transcription factors hepatocyte nuclear factor 4alpha, hepatocyte nuclear factor 1alpha, insulin promoter factor-1, hepatocyte nuclear factor 1beta and neuroD1. Additional MODY genes remain to be identified. The study of families with MODY has shown that the different MODY subtypes present different metabolic and clinical profiles. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11979019     DOI: 10.1159/000053309

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  11 in total

Review 1.  Epigenetics: spotlight on type 2 diabetes and obesity.

Authors:  A Desiderio; R Spinelli; M Ciccarelli; C Nigro; C Miele; F Beguinot; G A Raciti
Journal:  J Endocrinol Invest       Date:  2016-05-14       Impact factor: 4.256

Review 2.  [Molecular diagnosis of diabetes mellitus].

Authors:  U C Broedl; B Göke
Journal:  Internist (Berl)       Date:  2006-01       Impact factor: 0.743

3.  Aetiological heterogeneity of asymptomatic hyperglycaemia in children and adolescents.

Authors:  E Feigerlová; S Pruhová; L Dittertová; J Lebl; D Pinterová; K Kolostová; M Cerná; O Pedersen; T Hansen
Journal:  Eur J Pediatr       Date:  2006-04-07       Impact factor: 3.183

4.  Copy Number Variation in GCK in Patients With Maturity-Onset Diabetes of the Young.

Authors:  Amanda J Berberich; Céline Huot; Henian Cao; Adam D McIntyre; John F Robinson; Jian Wang; Robert A Hegele
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

5.  Absence of a reductase, NCB5OR, causes insulin-deficient diabetes.

Authors:  Jianxin Xie; Hao Zhu; Kevin Larade; Annie Ladoux; Ayden Seguritan; Michelle Chu; Susumu Ito; Roderick T Bronson; Edward H Leiter; Chen-Yu Zhang; Evan D Rosen; H Franklin Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

6.  Diagnosis of HNF-1alpha mutations on a PNA zip-code microarray by single base extension.

Authors:  Jae Yang Song; Hyun Gyu Park; Sung-Ouk Jung; JaeChan Park
Journal:  Nucleic Acids Res       Date:  2005-02-01       Impact factor: 16.971

7.  The impact of patents on the development of genome-based clinical diagnostics: an analysis of case studies.

Authors:  Brandon L Pierce; Christopher S Carlson; Patricia C Kuszler; Janet L Stanford; Melissa A Austin
Journal:  Genet Med       Date:  2009-03       Impact factor: 8.822

8.  GCK Mutation in a Child with Maturity Onset Diabetes of the Young, Type 2.

Authors:  Shahab Noorian; Fatemeh Sayarifard; Elham Farhadi; Fabrizio Barbetti; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2013-04       Impact factor: 0.364

9.  Evidence against a beneficial effect of irisin in humans.

Authors:  Silja Raschke; Manuela Elsen; Hans Gassenhuber; Mark Sommerfeld; Uwe Schwahn; Barbara Brockmann; Raphael Jung; Ulrik Wisløff; Arnt E Tjønna; Truls Raastad; Jostein Hallén; Frode Norheim; Christian A Drevon; Tania Romacho; Kristin Eckardt; Juergen Eckel
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

10.  Evaluation of a target region capture sequencing platform using monogenic diabetes as a study-model.

Authors:  Rui Gao; Yanxia Liu; Anette Prior Gjesing; Mette Hollensted; Xianzi Wan; Shuwen He; Oluf Pedersen; Xin Yi; Jun Wang; Torben Hansen
Journal:  BMC Genet       Date:  2014-01-29       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.